EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bile acid metabolism and signalling in liver disease

Claudia D Fuchs, Benedikt Simbrunner, Maximillian Baumgartner, Clarissa Campbell, Thomas Reiberger, Michael Trauner

Journal of Hepatology · 2025-01 · 82 (1) · 134-153

DOI: 10.1016/j.jhep.2024.09.032 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Hepatology, 2025-01. Verfasst von Claudia D Fuchs und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Bile Acids and Salts, Signal Transduction, Liver Diseases. Die Arbeit wurde bisher 262-mal zitiert (Crossref) und nennt 272 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Federation of European Biochemical Societies, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bile acids (BAs) serve as signalling molecules, efficiently regulating their own metabolism and transport, as well as key aspects of lipid and glucose homeostasis. BAs shape the gut microbial flora and conversely are metabolised by microbiota. Disruption of BA transport, metabolism and physiological signalling functions contribute to the pathogenesis and progression of a wide range of liver diseases including cholestatic disorders and MASLD (metabolic dysfunction-associated steatotic liver disease), as well as hepatocellular and cholangiocellular carcinoma. Additionally, impaired BA signalling may also affect the intestine and kidney, thereby contributing to failure of gut integrity and driving the progression and complications of portal hypertension, cholemic nephropathy and the development of extrahepatic malignancies such as colorectal cancer. In this review, we will summarise recent advances in the understanding of BA signalling, metabolism and transport, focusing on transcriptional regulation and novel BA-focused therapeutic strategies for cholestatic and metabolic liver diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bile Acids and SaltsSignal TransductionLiver DiseasesHumansAnimals

Stichwörter der Autor:innen

MicrobiotaTransportbile acid homeostasischolestatic and metabolic disease

Substanzen

Bile Acids and Salts

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, A…
  • CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria. Electronic address: michael.trauner@meduniwien.ac.at.

Förderung

  • Austrian Science Fund
  • Federation of European Biochemical Societies
  • European Commission

Zitieren

APA

Fuchs, C. D., Simbrunner, B., Baumgartner, M., Campbell, C., Reiberger, T., & Trauner, M. (2025). Bile acid metabolism and signalling in liver disease. Journal of Hepatology, 82(1), 134-153. https://doi.org/10.1016/j.jhep.2024.09.032

Vancouver

Fuchs CD, Simbrunner B, Baumgartner M, Campbell C, Reiberger T, Trauner M. Bile acid metabolism and signalling in liver disease. Journal of Hepatology. 2025;82(1):134-153. doi:10.1016/j.jhep.2024.09.032

BibTeX
@article{Fuchs2025,
  author = {Fuchs, Claudia D and Simbrunner, Benedikt and Baumgartner, Maximillian and Campbell, Clarissa and Reiberger, Thomas and Trauner, Michael},
  title = {Bile acid metabolism and signalling in liver disease},
  journal = {Journal of Hepatology},
  year = {2025},
  volume = {82},
  number = {1},
  pages = {134--153},
  doi = {10.1016/j.jhep.2024.09.032}
}
Kostenlos starten →